Who We Are

The New Jersey Life Sciences Vendors Alliance (NJLSVA) is a coalition of businesses, individuals and academia who provide goods and services to New Jersey’s life sciences companies.

The NJLSVA was founded to educate suppliers on trends in industry procurement and public policy that affects the life sciences industry.

Choose NJ’s RFP Watch

Choose New Jersey’s RFP Watch provides up-to-date information on business opportunities throughout the Garden State at a cost that is affordable for all companies – with a place of business in New Jersey – large and small.

To learn more click here

Congress

Patients and Families Make Emotional Plea at Senate Hearing for Diabetes Research Funding

Washington, DC, July 27, 2017 — Summer Park reports on Roll Call that families and advocates delivered an emotional plea for more diabetes research funding before Congress on July 26.

People with type 1 diabetes, including over 160 children, were on hand for a hearing before the Senate Special Committee on Aging.

Those testifying urged lawmakers to extend the Special Diabetes Program, which funds research into type 1 diabetes.  The program will run out of funds this September if lawmakers don’t act. Continue reading

Report: States’ Federal Medicaid Funding Could Drop 39 Percent Over Two Decades Under GOP Plan

Washington, DC, July 17, 2017The Hill reports that federal Medicaid funding could drop by as much as 39 percent over the next two decades under Senate Republicans’ healthcare plan, according to a report presented at the National Governors Association meeting.

The report, authored by the consulting firm Avalere Health, estimates that the GOP’s plan to overhaul large parts of the country’s healthcare system would offer deep cuts to Medicaid, ranging from 27 to 39 percent.

Among the states that would be hit the hardest by the cuts are California, Washington, Oregon, Nevada, New Mexico, North Dakota, Minnesota and Kentucky, among others that would see funding reductions of 35 percent or more. Continue reading

Opinion: NJAMHAA Mary Abrams Urges NJ’s Members of Congress to Reject GOP Interference with Medicare Part D

New Brunswick, NJ, July 13, 2017In a Star-Ledger opinion piece published on July 12, Mary Abrams, Senior Health Policy Analyst at the New Jersey Association of Mental Health and Addiction Agencies (NJAMHAA), writes:

Congress could soon weaken prescription drug coverage for more than 900,000 New Jersey residents.  Lawmakers want to fundamentally alter Medicare Part D, which has provided seniors and the disabled with affordable medicines for more than a decade.

The program has become a lifeline.  Without Part D, nearly two out of three seniors say that they would be unable to fill all of their prescriptions, while one in two say that they would be more likely to cut back or stop taking their medicines altogether. Continue reading

U.S. House Subcommittee Defies Trump’s Budget and Proposes $1.1 Billion Boost for NHI

Washington, DC, July 13, 2017 — Rachel Roubein reports in The Hill that the U.S. House of Representatives subcommittee controlling the purse strings of the National Institutes of Health (NIH) on July 12 proposed a $1.1 billion boost for the agency, defying the Trump administration’s push for cuts.

The White House had proposed slashing the nation’s medical research agency by $5.8 billion.

But it was clear from the get-go that Congress wouldn’t support cutting NIH’s budget, with members of both parties in opposition. Continue reading

Opinion: Former Merck CEO and Princeton University President Emeritus on ‘Trump’s War on Science Threatens U.S. Prosperity’

Princeton, NJ, July 6, 2017Roy Vagelos, retired Chairman and CEO of Merck & Co. and Chairman of the Board of Regeneron Pharmaceuticals, and Shirley Tilghman, President Emeritus of Princeton University and a professor of Molecular Biology and Public Affairs, published the following opinion piece in The Star-Ledger on June 6:

In the past 40 years, the U.S. has been the world leader in converting fundamental scientific discoveries into innovative new treatments for life-threatening disease.  New drugs, vaccines, and medical devices have improved human health and increased our lifespan.

In this time, the treatment of cardiovascular disease has been transformed, HIV medications have been developed that mean AIDS is no longer a death sentence, and within the last five years, revolutionary new drugs that work through the activation of the immune system are now successfully treating some forms of cancer. Continue reading

SSTI: U.S. House Appropriations Bills Would Make Major Cuts to Innovation

Westerville, OH, July 1, 2017 ― Jason Rittenberg reports on the State Science & Technology Institute (SSTI) news blog that the U.S. House Appropriations Committee began releasing FY 2018 “markup” budget bills at the end of June, and the proposals would cut billions in non-defense spending.

EDA would lose $117 million in program funding, SBA’s entrepreneurial development programs would lose $34 million, NIST’s Manufacturing Extension Partnership would lose $30 million, and Energy’s ARPA-E would be eliminated, among other cuts. Continue reading

Quinnipiac Poll: U.S. Voters Reject GOP Health Plan More Than 3-1; Oppose Medicaid and Planned Parenthood Cuts

Hamden, Connecticut, June 29, 2017 — Despite its new name and some tweaks, American voters disapprove 58 to 16 percent of the Republican health care plan to replace Obamacare, according to a Quinnipiac University national poll released June 28.

Disapproval of various versions of the Republican health care plan ranges from 56 to 21 percent to 62 to 17 percent in surveys by the independent Quinnipiac University conducted since March.

On March 24, the House of Representatives cancelled a vote on its first health care bill after a Quinnipiac University poll showed voters disapproved 56 to 17 percent. Continue reading

Study: NJ Would See Job Loss Under House GOP’s Obamacare Repeal and Replace Proposal

Washington, DC, June 19, 2017 — Jonathan D. Salant reports in The Star-Ledger/NewJersey.com that New Jersey would lose more jobs than all but five other states under the House Republican health care bill, according to a study released June 14.

The Garden State would lose 42,000 jobs by 2026, behind only New York, Pennsylvania, Florida, Michigan, and Illinois, according to the study by George Washington University’s Milken Institute School of Public Health and the Commonwealth Fund, a foundation that supports efforts to increase health coverage.

Overall, according to the study, the 10 states with the largest job losses by 2026 are:

  1. New York (86,000)
  2. Pennsylvania (85,000)
  3. Florida (83,000)
  4. Michigan (51,000)
  5. Illinois (46,000)
  6. New Jersey (42,000)
  7. Ohio (42,000)
  8. North Carolina (41,000)
  9. California (32,000)
  10. Tennessee (28,000).

Continue reading

Opinion: Former Merck CEO and Princeton University President Emeritus on ‘Trump’s War on Science Threatens U.S. Prosperity’

Princeton, NJ, June 12, 2017Roy Vagelos, retired Chairman and CEO of Merck & Co. and Chairman of the Board of Regeneron Pharmaceuticals, and Shirley Tilghman, President Emeritus of Princeton University and a professor of Molecular Biology and Public Affairs, published the following opinion piece in The Star-Ledger on June 6:

In the past 40 years, the U.S. has been the world leader in converting fundamental scientific discoveries into innovative new treatments for life-threatening disease.  New drugs, vaccines, and medical devices have improved human health and increased our lifespan. Continue reading

Trump to Keep Dr. Francis Collins as Director of National Institutes of Health

Dr. Francis Collins

Washington, DC, June 7, 2017The Washington Post reports that the White House yesterday announced that Francis S. Collins will stay on as Director of the National Institutes of Health, extending Collins’s tenure even as the Trump administration proposes deep cuts to the government’s premier biomedical research center.

Dr. Collins, a physician and geneticist, has led NIH since 2009.

Collins is renowned for his leadership of the International Human Genome Project, which in 2003 sequenced the complete human genetic blueprint for the first time. Continue reading